These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 16193174

  • 1. CD44 splicing pattern is associated with disease progression in pulmonary adenocarcinoma.
    Lee LN, Kuo SH, Lee YC, Chang YL, Chang HC, Jan IS, Yang PC.
    J Formos Med Assoc; 2005 Aug; 104(8):541-8. PubMed ID: 16193174
    [Abstract] [Full Text] [Related]

  • 2. Reduced expression of CD44v3 variant isoform is associated with unfavorable outcome in non-small cell lung carcinoma.
    Pirinen R, Hirvikoski P, Böhm J, Kellokoski J, Moisio K, Virén M, Johansson R, Hollmén S, Kosma VM.
    Hum Pathol; 2000 Sep; 31(9):1088-95. PubMed ID: 11014576
    [Abstract] [Full Text] [Related]

  • 3. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN, Mirejovský T, Melinová L, Mandys V.
    Neoplasma; 2000 Sep; 47(6):400-8. PubMed ID: 11263866
    [Abstract] [Full Text] [Related]

  • 4. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.
    Miyoshi T, Kondo K, Hino N, Uyama T, Monden Y.
    Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811
    [Abstract] [Full Text] [Related]

  • 5. The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomy.
    Noordzij MA, van Steenbrugge GJ, Verkaik NS, Schröder FH, van der Kwast TH.
    Clin Cancer Res; 1997 May; 3(5):805-15. PubMed ID: 9815753
    [Abstract] [Full Text] [Related]

  • 6. Preferential histiotypic expression of CD44-isoforms in human lung cancer.
    Wimmel A, Schilli M, Kaiser U, Havemann K, Ramaswamy A, Branscheid D, Kogan E, Schuermann M.
    Lung Cancer; 1997 Mar; 16(2-3):151-72. PubMed ID: 9152947
    [Abstract] [Full Text] [Related]

  • 7. Expression of CD44 variant exon 6 in stage I non-small cell lung carcinoma as a prognostic factor.
    Hirata T, Fukuse T, Naiki H, Hitomi S, Wada H.
    Cancer Res; 1998 Mar 15; 58(6):1108-10. PubMed ID: 9515789
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of immunohistochemically detected CD44 expression in patients with carcinoma of the vulva.
    Tempfer C, Gitsch G, Haeusler G, Reinthaller A, Koelbl H, Kainz C.
    Cancer; 1996 Jul 15; 78(2):273-7. PubMed ID: 8674003
    [Abstract] [Full Text] [Related]

  • 9. CD44 alternative splicing and hnRNP A1 expression are associated with the metastasis of breast cancer.
    Loh TJ, Moon H, Cho S, Jang H, Liu YC, Tai H, Jung DW, Williams DR, Kim HR, Shin MG, Liao DJ, Zhou J, Shi W, Zheng X, Shen H.
    Oncol Rep; 2015 Sep 15; 34(3):1231-8. PubMed ID: 26151392
    [Abstract] [Full Text] [Related]

  • 10. Isoform expression of CD44 adhesion molecules, Bcl-2, p53 and Ki-67 proteins in lung cancer.
    Mizera-Nyczak E, Dyszkiewicz W, Heider KH, Zeromski J.
    Tumour Biol; 2001 Sep 15; 22(1):45-53. PubMed ID: 11054026
    [Abstract] [Full Text] [Related]

  • 11. Expression of CD44 in primary lung carcinomas using histological and cytological analyses.
    Shimbori M, Kijima H, Sato S, Yoshida H, Sato T, Terasaki-Fukuzawa Y, Onoda N, Kanabuchi K, Abe Y, Nakamura M, Hattori M, Ohno E, Kuramoto H.
    Anticancer Res; 2003 Sep 15; 23(1A):115-21. PubMed ID: 12680202
    [Abstract] [Full Text] [Related]

  • 12. Alternative splicing variants of carbonic anhydrase IX in human non-small cell lung cancer.
    Malentacchi F, Simi L, Nannelli C, Andreani M, Janni A, Pastorekova S, Orlando C.
    Lung Cancer; 2009 Jun 15; 64(3):271-6. PubMed ID: 19022520
    [Abstract] [Full Text] [Related]

  • 13. Distinct CD44 splice variants differentially affect collateral artery growth.
    Bot PT, Grundmann S, van Royen N, Joosten SP, Schirmer SH, de Kleijn DP, Pals ST, Pasterkamp G, Piek JJ, Hoefer IE.
    Curr Vasc Pharmacol; 2013 Jan 15; 11(1):13-20. PubMed ID: 23391418
    [Abstract] [Full Text] [Related]

  • 14. Influence of epitopes CD44v3 and CD44v6 in the invasive behavior of fibroblast-like synoviocytes derived from rheumatoid arthritic joints.
    Wibulswas A, Croft D, Pitsillides AA, Bacarese-Hamilton I, McIntyre P, Genot E, Kramer IM.
    Arthritis Rheum; 2002 Aug 15; 46(8):2059-64. PubMed ID: 12209509
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic utility of CD44 standard, CD44v6, and CD44v3-10 expression in adenocarcinomas presenting in serous fluids.
    Afify A, Pang L, Howell L.
    Appl Immunohistochem Mol Morphol; 2007 Dec 15; 15(4):446-50. PubMed ID: 18091389
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer.
    Kainz C, Tempfer C, Kohlberger P, Janisch S, Koelbl H, Gitsch G, Breitenecker G.
    Int J Cancer; 1996 Jun 21; 69(3):170-3. PubMed ID: 8682582
    [Abstract] [Full Text] [Related]

  • 17. [Expression of standard and variant CD44 in human lung cancer].
    Zhao H, Fang J, Du G.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Sep 21; 21(9):541-3. PubMed ID: 11360506
    [Abstract] [Full Text] [Related]

  • 18. Frequent expression of the high molecular, 673-bp CD44v3,v8-10 variant in colorectal adenomas and carcinomas.
    Kopp R, Fichter M, Schalhorn G, Danescu J, Classen S.
    Int J Mol Med; 2009 Nov 21; 24(5):677-83. PubMed ID: 19787202
    [Abstract] [Full Text] [Related]

  • 19. Prognostic value of CD44 variant exon 6 expression in non-small cell lung cancer: a meta-analysis.
    Zhao S, He JL, Qiu ZX, Chen NY, Luo Z, Chen BJ, Li WM.
    Asian Pac J Cancer Prev; 2014 Nov 21; 15(16):6761-6. PubMed ID: 25169522
    [Abstract] [Full Text] [Related]

  • 20. Restricted patterns of CD44 variant exon expression in human papillary thyroid carcinoma.
    Ermak G, Jennings T, Robinson L, Ross JS, Figge J.
    Cancer Res; 1996 Mar 01; 56(5):1037-42. PubMed ID: 8640758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.